KATELIN TAMBASCO: Open Payments
NPI 1134752355 · SMITHTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,324 in 105 payments from 20 companies in 2025. Trend: 2023 $2,321 · 2024 $1,686 · 2025 $2,324
Food & beverage: $2,324
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 12 | $410 |
| LEO Pharma Inc. | 24 | $368 |
| GENZYME CORPORATION | 6 | $281 |
| Novartis Pharmaceuticals Corporation | 14 | $277 |
| ABBVIE INC. | 9 | $201 |
| Regeneron Healthcare Solutions, Inc. | 6 | $147 |
| PFIZER INC. | 6 | $113 |
| Organon LLC | 6 | $87 |
| UCB, Inc. | 4 | $83 |
| Incyte Corporation | 3 | $56 |
Products named: Zoryve, DUPIXENT, ADBRY, COSENTYX, SKYRIZI, ANZUPGO, CIBINQO, VTAMA.
Industry payments across NY — which companies pay providers there.
